Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 0829320130160010001
Korean Journal of Clinical Microbiology
2013 Volume.16 No. 1 p.1 ~ p.7
Anti-Tuberculosis Drug Resistant Rates in Mycobacterium tuberculosis Isolated from Respiratory Specimens:A Multicenter Study in Korea
Kim Ja-Young

Park Yeon-Joon
Chang Chul-Hun
Lee Mi-Ae
Lee Nam-Yong
Shin Jong-Hee
Abstract
Background: We analyzed the prevalence of anti-tuberculosisdrug resistance in Mycobacterium tuberculosis isolates from respiratory specimens of patientswith newly diagnosed and previously treated tuberculosis.
Methods: From February 2010 to July 2010, a total of 542 M. tuberculosis clinical isolates were collected from pulmonary tuberculosis patients in six university hospitals distributed throughout Korea. We analyzedthe results of anti-tuberculosis drug resistance testsaccording to treatment history and geographic location.
Results: Among the 542 isolates, 473 (87.3%) were from newly diagnosed cases and 69 (12.7%) were from previously treated cases. The rates of multi-drug resistance (MDR), fluoroquinolone (ofloxacin, levofloxacin, and moxifloxacin) resistance, and extensive drug resistance (XDR) were 3.8%, 1.1-1.5%, and 0%,respectively, in new cases, and 21.7%, 13.0-17.4%, and 4.3%, respectively, in previously treated cases. In the previously treated cases, the proportions of XDR-TB in MDR-TB were 20% (3/15). The resistance rates were variable according to geographic location.
Conclusion: As the anti-tuberculosis drug resistance rates are much higher in newly diagnosed cases than in previously treated patients, efforts should be made to ensure that tuberculosis treatment is successful. Inaddition, before the selection of an anti-tuberculosis drug treatment for previously treated patients, the susceptibility test results, including to fluoroquinolone,should be verified.
KEYWORD
Anti-tuberculosis drug resistant rates, Extensive drug resistance, Multi-drug resistance, Mycobacterium tuberculosis
FullTexts / Linksout information
 
Listed journal information
ÇмúÁøÈïÀç´Ü(KCI) KoreaMed ´ëÇÑÀÇÇÐȸ ȸ¿ø